Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Type 2 Diabetic Patients
100%
Renin-angiotensin System Inhibitors
100%
Volume Status
100%
Dapagliflozin
100%
Lithium
60%
Placebo
40%
Kidney Injury
40%
Diuretic Effect
40%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
40%
Sodium Reabsorption
40%
Urinary Osmolality
40%
Confidence Interval
20%
Randomized Controlled Trial
20%
Healthy Individuals
20%
Treatment Duration
20%
Placebo-controlled Study
20%
End of Treatment
20%
Heart Failure
20%
Renin
20%
Urinary Glucose Excretion
20%
Albumin-to-creatinine Ratio
20%
Sodium
20%
Volume Change
20%
Kidney Failure
20%
24-hour Urine Collection
20%
Compensatory Mechanisms
20%
Free Water Clearance
20%
Proximal Tubular
20%
Copeptin
20%
Preserved Renal Function
20%
Proximal Tubule
20%
Two-kidney
20%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Renin-Angiotensin System Inhibitor
100%
Dapagliflozin
100%
Placebo
40%
Renin
40%
Diuretic Agent
40%
Kidney Injury
40%
Sodium Glucose Cotransporter 2 Inhibitor
40%
Placebo-Controlled Study
20%
Randomized Controlled Trial
20%
Angiotensin
20%
Creatinine
20%
Heart Failure
20%
Kidney Failure
20%
Glucosuria
20%
Copeptin
20%